|
Class of 2001 Theodore Castele
Term: 1999–2001
Dr. Castele bridges the worlds of medicine, public health, media, business, higher education, and philanthropy. As a radiologist, he has a deep appreciation for and understanding of medical research. As "Dr. Ted" of Cleveland's TV Channel 5 (an ABC affiliate) and a television medical editor, he distills and translates that research into almost daily news reports that keep residents of Northeast Ohio abreast of breaking developments in medicine and science. A successful businessman, a community leader, and a physician, Dr. Castele brings a unique blend of skills to the work of boards, committees, and associations. He is known as a goodwill ambassador for his alma mater, the Case Western Reserve University School of Medicine, is the Chair for both the Dean's Technology Council and the CWRU Capital Campaign, and is an advisory board member of the school's Center for Aging and Health. He is Chairman of the Board for the Health Museum of Cleveland and the Centers of Dialysis Care, and he has served or is currently serving on the boards of the American Lung Association/Northern Ohio Division, the American Cancer Society, the National Osteoporosis Foundation?Ohio Chapter, and the Boy Scouts of America, the latter position continuing an involvement Dr. Castele traces back to his days as an Eagle Scout. He also serves on the Council of the American College of Radiology and Ursuline Nuns of Cleveland Advisory Board. Previous activities include serving as the Chief of Medical Staff at Cleveland's Lutheran Medical Center and as president of the Academy of Medicine of Cleveland, the Cleveland Radiological Society, the Medical Alumni Association, the Lutheran Medical Association, and the board of consultants for the Safety Department of the Cleveland Medical Bureau.
Robin Chin
Term: 1999–2001
Ms. Chin is a pharmacist and the current chairperson of the National Asian Women's Health Organization's (NAWHO's) board of directors. She takes an active role in communicating health information to the 9.2 million Asian Americans living in the United States. She has a special commitment to improving conditions within medically underserved communities in Rhode Island and Massachusetts. This professional focus reflects her dedication to her local community and her determination to help end gender and ethnic health disparities. A breast cancer survivor, HIV/AIDS advocate, and diabetes educator, she shares her personal experience with breast cancer by speaking at conferences and community forums to dispel the view commonly held by Asian American women that breast cancer is a shameful disease and always fatal. In 1998, Ms. Chin participated in NAWHO's National Clinical Trials and Asian American Women Summit, which brought scientific and advocacy communities together at the National Institutes of Health, with the goal of making clinical trials more accessible to Asian American women. A preceptor of pharmacy practice at her alma mater, the University of Rhode Island, Ms. Chin is a pharmacy manager for CVS located in North Attleboro, an American Cancer Society board member, and a Reach to Recovery volunteer for the American Cancer Society.
Mary desVignes-Kendrick
Term: 1999–2001
Dr. desVignes-Kendrick is Director of Health and Human Services for Houston, Texas, the fourth largest city in the nation. She is particularly interested in outcome disparities among various ethnic groups and in the process of narrowing those gaps. As a physician and Board-certified pediatrician, she is committed to providing excellent health care; as a public health practitioner, she is equally committed to preventing disease before its onset. Her vision of improving public health for the economically and culturally diverse population of Houston reaches beyond the realm of medicine to providing a range of social services through multi-service centers and to ensuring equal access to public health services. Under her leadership, Houston has reported significant improvements in infant mortality rates and infant immunization. Dr. desVignes-Kendrick has also led investigations of endemic and imported communicable disease outbreaks in Houston, and she is experienced in environmental investigations. She is past President of the National Association of County and City Health Officials, an organization that represents nearly 3,000 local health departments nationwide, and she is a member of the National Vaccine Advisory Committee. She earned her medical degree at Meharry Medical College and completed her pediatric residency at Baylor College of Medicine, where she served as assistant professor in the department of community medicine. She received a Master of Public Health degree from the University of Texas School of Public Health in Houston. A partial listing of her awards includes: the American Public Health Association's 1997 Milton and Ruth Roemer Award for creative local public health work, the National Forum for Black Public Administrators' Certificate for Commitment to Excellence and Service to the Public, and the National Organization for the Professional Advancement of Black Chemists and Chemical Engineers' Top Doc Award. She and her husband, Ernest A. Kendrick, a psychiatrist that works with children and adolescents, have three children, Aziza, Jelani, and Shomari.
David Frohnmayer
Term: 1999–2001
Dr. Frohnmayer is President of the University of Oregon, a major research institution with strong programs in biology and neuroscience. He and his wife, Lynn Diane Frohnmayer, co-founded the Fanconi Anemia Research Fund after their three daughters were diagnosed with this rare congenital disease. Dr. Frohnmayer has used his concern for his own children to assist other families affected by this complex medical condition, to stimulate a better understanding of the disorder, and to develop sources of financial support for medical research. The Fanconi Anemia Research Fund provides seed money to help scientists develop preliminary results needed to generate research proposals competitive for NIH funding. Dr. Frohnmayer estimates that laboratories whose early work was supported by the Research Fund have received more than $13 million in NIH support. He is a past member of the board of directors for the Fred Hutchinson Cancer Research Center and the National Marrow Donor Program and has participated actively in professional and civic associations, including the National Association of Attorneys General, the Governor's Special Commission Against Violent Crime, the Oregon Federation of Parents for a Drug-Free Youth, the Oregon Special Olympics, and the Children's Miracle Network Telethon. He has been elected to three terms in the Oregon Legislative Assembly and to three terms as Oregon Attorney General. On the national level, he was Assistant to the Secretary of what was then the U.S. Department of Health, Education, and Welfare and consultant to the Civil Rights Division of the U.S. Department of Justice. A graduate of Harvard College, Dr. Frohnmayer attended Oxford University as a Rhodes Scholar and earned his law degree from the University of California in Berkeley. The Frohnmayers are authors of Fanconi Anemia: A Handbook for Families and Their Physicians. In 2000 the Frohnmayers were honored with two national awards: Research! America's Advocacy Award and the Americans for Medical Progress Educational Foundation's Albert B. Sabin Heroes of Science Award. They have one surviving daughter and two sons.
Lydia Lewis
Term: 1999–2001
Ms. Lewis, in her leadership position as Executive Director of the National Depressive and Manic-Depressive Association (National DMDA), has worked to remove the stigma from mental illness and to build public understanding of people with mood disorders. With more than 400 support groups across the United States and Canada, National DMDA is the country's largest patient-run, illness-specific nonprofit organization committed to advocating for research toward the elimination of mood disorders. National DMDA also works to inform patients, professionals, and the public that mood disorders are treatable; to foster self-help among people and families living with these illnesses; to eliminate discrimination and stigma against these individuals; and to improve access to care. Having joined the National DMDA staff in 1997, Ms. Lewis is credited with revitalizing the organization at a time when it seemed unlikely to continue and establishing strong cooperative relationships with other organizations, even though she had only worked with the organization less than two years. She currently serves on a joint task force of NIH's National Institute of Mental Health (NIMH) and National Center for Complementary and Alternative Medicine that is overseeing a clinical trial on St. John's wort, and she serves on the NIMH Oversight committees for the Star*D, TADS, and Step-BD clinical trials. She has published several articles in peer-reviewed journals and has presented at a wide range of mental health conferences. National DMDA was an active partner in NIMH's D/ART Program, promoting awareness of depression in the workplace. National DMDA's primary goal is to educate the general public, the media, medical professionals and legislators that mood disorders are treatable medical illnesses. Another goal is to ensure that the National DMDA provides strong links among mental health consumers, family members, and researchers and clinicians across the nation. Before joining National DMDA, Ms. Lewis worked at AT&T and was responsible for employee morale concerns during the period of its divestiture from the Bell Operating Companies. Ms. Lewis also served 11 years as Executive Director of The Committee of 200, an international nonprofit organization of preeminent women business owners and executives.
Maurice F. Rabb
Term: 1999–2001
Dr. Rabb is Medical Director of Prevent Blindness America, a national volunteer eye health and safety organization serving millions each year through public and professional education, community and patient services, and medical research. A practicing ophthalmologist and clinical researcher, Dr. Rabb heads the Department of Ophthalmology and is President of the medical staff at Chicago's Mercy Hospital and Medical Center. Dr. Rabb is also Professor of Ophthalmology at the University of Illinois at Chicago. He has been active in the development of fluorescein angiography and has also made significant contributions to advancing public health through his service on advisory panels and committees. His research interests focus on understanding the effects of systemic diseases, such as diabetes, on the eye. Dr. Rabb has received support from NIH during his career and has served as a member of the Macula Society, the National Eye Institute's Eye Advisory Council, and as Chair of NIH's Sickle Cell Disease Advisory Council. He has also held positions as Acting Associate Chancellor and Interim Associate Vice Chancellor for Urban Health at the University of Illinois at Chicago. Dr. Rabb is active in the American Academy of Ophthalmology, the National Medical Association, and the Chicago Ophthalmological Society.
|
|